Cargando…

Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration

Children with solid tumors represent a unique population. Recent improvements in pediatric solid tumor survival rates have been confined to low- and moderate-risk cancers, whereas minimal to no notable improvement in survival have been observed in high-risk and advanced-stage childhood tumors. Treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loh, Amos H. P., Brennan, Rachel C., Lang, Walter H., Hickey, Robert J., Malkas, Linda H., Sandoval, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636761/ https://www.ncbi.nlm.nih.gov/pubmed/23638435 http://dx.doi.org/10.3389/fonc.2013.00093

Ejemplares similares

Clinical Significance of Serum Biomarkers in Pediatric Solid Mediastinal and Abdominal Tumors
por: Sandoval, John A., et al.
Publicado: (2012)

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
por: Xiang, Yubo, et al.
Publicado: (2023)

Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies
por: Tasian, Sarah K., et al.
Publicado: (2014)

Therapeutic Targeting of DNA Replication Stress in Cancer
por: Gu, Long, et al.
Publicado: (2023)

Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma
por: Wong, Rachel L. Y., et al.
Publicado: (2021)

A PCNA-Derived Cell Permeable Peptide Selectively Inhibits Neuroblastoma Cell Growth
por: Gu, Long, et al.
Publicado: (2014)

Downregulation of MYCN through PI3K Inhibition in Mouse Models of Pediatric Neural Cancer
por: Cage, Tene Aneka, et al.
Publicado: (2015)

Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
por: Ortiz, Michael V., et al.
Publicado: (2019)

Editorial: Evolving roles of piRNAs in solid tumors
por: Ng, Lui, et al.
Publicado: (2023)

PI3K Pathway in NSCLC
por: Martinez-Martí, Alex, et al.
Publicado: (2012)

PI3K Promotes Basal Cell Carcinoma Growth Through Kinase-Induced p21 Degradation
por: Chow, Rachel Y., et al.
Publicado: (2021)

Genetic Predisposition to Solid Pediatric Cancers
por: Capasso, Mario, et al.
Publicado: (2020)

Loss of the Fbw7 tumor suppressor rewires cholesterol metabolism in cancer cells leading to activation of the PI3K-AKT signalling axis
por: Bengoechea-Alonso, Maria T., et al.
Publicado: (2022)

FOXM1 Promotes Head and Neck Squamous Cell Carcinoma via Activation of the Linc-ROR/LMO4/AKT/PI3K Axis
por: Ma, Xiao, et al.
Publicado: (2021)

Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
por: Cintas, Célia, et al.
Publicado: (2018)

Targeted treatment of solid tumors in pediatric precision oncology
por: Bertacca, Ilaria, et al.
Publicado: (2023)

Combined Scutellarin and C(18)H(17)NO(6) Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis
por: He, Xiu-Ying, et al.
Publicado: (2021)

Targeting PI3K in Cancer: Any Good News?
por: Martini, Miriam, et al.
Publicado: (2013)

Targeting PI3K/mTOR Signaling in Cancer
por: Arcaro, Alexandre
Publicado: (2014)

Does Ras Activate Raf and PI3K Allosterically?
por: Nussinov, Ruth, et al.
Publicado: (2019)

Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition
por: Conciatori, Fabiana, et al.
Publicado: (2022)

Extracellular Vesicles: A New Source of Biomarkers in Pediatric Solid Tumors? A Systematic Review
por: Lak, Nathalie S. M., et al.
Publicado: (2022)

Corrigendum: Combined Scutellarin and C(18)H(17)NO(6) Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis
por: He, Xiu-Ying, et al.
Publicado: (2022)

Partial Purification of a Megadalton DNA Replication Complex by Free Flow Electrophoresis
por: Li, Caroline M., et al.
Publicado: (2016)

Genomic Determinants of PI3K Pathway Inhibitor Response in Cancer
por: Weigelt, Britta, et al.
Publicado: (2012)

Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014)

CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma
por: Zheng, Zaosong, et al.
Publicado: (2019)

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
por: Carnero, Amancio, et al.
Publicado: (2014)

The PTEN–PI3K Axis in Cancer
por: Papa, Antonella, et al.
Publicado: (2019)

Hepatitis B Virus Seropositivity Is a Poor Prognostic Factor of Pediatric Hepatocellular Carcinoma: a Population-Based Study in Hong Kong and Singapore
por: Liu, Anthony P. Y., et al.
Publicado: (2020)

The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway
por: Papoff, Giuliana, et al.
Publicado: (2023)

Prophylactic Central Neck Dissection to Improve Disease-Free Survival in Pediatric Papillary Thyroid Cancer
por: Ngo, Duy Quoc, et al.
Publicado: (2022)

Extracellular Matrix Protein 1 Regulates Colorectal Cancer Cell Proliferative, Migratory, Invasive and Epithelial-Mesenchymal Transition Activities Through the PI3K/AKT/GSK3β/Snail Signaling Axis
por: Long, Sirui, et al.
Publicado: (2022)

Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer
por: Fox, Emily M., et al.
Publicado: (2012)

Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets
por: Saada-Bouzid, Esma, et al.
Publicado: (2019)

CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis
por: Shi, Zuowei, et al.
Publicado: (2021)

Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
por: Cangemi, Michela, et al.
Publicado: (2019)

YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma via PI3K/AKT Signaling
por: Fan, Xiaoqin, et al.
Publicado: (2021)

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
por: Ruan, Yongsheng, et al.
Publicado: (2021)

Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer
por: Wanigasooriya, Kasun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iak1jjm78lna68nk8989nfntib